New ATC 3rd and 4th levels 2024
| ATC code | New name/new ATC 4th level |
|---|---|
| A10XX | Other drugs used in diabetes |
| C02KN | Other antihypertensives |
| C05X | OTHER VASOPROTECTIVES |
| C05XX | Other vasoprotectives |
| L01FY | Combinations of monoclonal antibodies and antibody drug conjugates |
| L04AE | Sphingosine-1-phosphate (S1P) receptor modulators |
| L04AF | Janus-associated kinase (JAK) inhibitors |
| L04AG | Monoclonal antibodies |
| L04AH | Mammalian target of rapamycin (mTOR) kinase inhibitors |
| L04AJ | Complement inhibitors |
| L04AK | Dihydroorotate dehydrogenase (DHODH) inhibitors |
| N05CJ | Orexin receptor antagonists |
Last updated: 2023-12-12